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Abstract
Background: Immunologists often measure several correlated immunological markers, such as concentrations of
different cytokines produced by different immune cells and/or measured under different conditions, to draw insights
from complex immunological mechanisms. Although there have been recent methodological efforts to improve the
statistical analysis of immunological data, a framework is still needed for the simultaneous analysis of multiple, often
correlated, immune markers. This framework would allow the immunologists’ hypotheses about the underlying
biological mechanisms to be integrated.
Results: We present an analytical approach for statistical analysis of correlated immune markers, such as those commonly
collected in modern immuno-epidemiological studies. We demonstrate i) how to deal with interdependencies among
multiple measurements of the same immune marker, ii) how to analyse association patterns among different markers,
iii) how to aggregate different measures and/or markers to immunological summary scores, iv) how to model the
inter-relationships among these scores, and v) how to use these scores in epidemiological association analyses. We
illustrate the application of our approach to multiple cytokine measurements from 818 children enrolled in a large
immuno-epidemiological study (SCAALA Salvador), which aimed to quantify the major immunological mechanisms
underlying atopic diseases or asthma. We demonstrate how to aggregate systematically the information captured in
multiple cytokine measurements to immunological summary scores aimed at reflecting the presumed underlying
immunological mechanisms (Th1/Th2 balance and immune regulatory network). We show how these aggregated
immune scores can be used as predictors in regression models with outcomes of immunological studies (e.g. specific
IgE) and compare the results to those obtained by a traditional multivariate regression approach.
Conclusion: The proposed analytical approach may be especially useful to quantify complex immune responses in
immuno-epidemiological studies, where investigators examine the relationship among epidemiological patterns,
immune response, and disease outcomes.
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Background
Basic and experimental research during recent years
has advanced our understanding of immune-regulatory
mechanisms in health and disease. An example is the
concept of Th1 versus Th2 responses applied in
immuno-epidemiological studies [1] aiming to identify
causal pathways linking immunological mechanisms to
health outcomes such as allergy. To investigate possible
pathways in epidemiological studies, researchers regress
clinical outcomes or surrogate endpoints to heteroge-
neous predictor variables collected from large popula-
tions. Immuno-epidemiologists typically enumerate
immunological mechanisms of interest by collecting
various immune biomarkers presumed to result from
different immune cells. For example, in allergy research,
researchers obtain concentrations of different cytokines
presumed to result from Th1, Th2, or T-Reg cells from
cell cultures under different immunological conditions.
The cytokine measurements are assumed to character-
ise the major immunological pathways involved in the
development of atopic diseases, i.e. the Th1/Th2 bal-
ance and immune regulation (Fig. 1) [2–5].
Researchers often have to deal with several peculiar-
ities of such immunological data [6]. These include non-
normality of distributions due to substantial skewness or
the existence of non-detectable values (“non-detects” are
concentrations of a marker below the detection limit of
an assay). For each of these problems, statistical ap-
proaches have been proposed: robust methods to deal
with the non-normality [7], imputation techniques to
deal with “non-detects” [8], use of Kaplan-Meier analysis
for censored data [9], advanced regression models for
non-normal data (Tobit- or Quantile regression) [10, 11],
and methods for the analysis of repeated immunological
measures [12]. These methodological advances have sub-
stantially improved the use of a few immunological pa-
rameters, such as outcomes or predictor variables, in
classical regression approaches.
However, recent progress in analytical methods has
considerably increased the number of immune markers
to be collected in immuno-epidemiological studies.
Markers are often highly correlated and immunologists
have already embraced the appropriate “latent variable”
approach by considering a battery of correlated immune
markers, like cytokines, as indicators of underlying latent
mechanisms (Fig. 1). Previously applied approaches
incorporating the idea of latent variables have been pre-
dominantly data driven, such as principal component
analysis [13, 14] or latent class analysis [15]. Other au-
thors have used simple summary measures of biologic-
ally unrelated immune responses, such as ratios of
distinct immune responses (e.g. Th1/Th2 ratio) [4].
What is missing is an analytical strategy that additionally
incorporates the immunologists’ hypothesised under-
lying biological mechanisms and uses appropriate and
easy-to-follow statistical procedures.
Unfortunately, due to the inherent difficulty of apply-
ing these more sophisticated statistical approaches, re-
searchers still use simple analytical approaches for
multiple markers. Common strategies are to analyse
each marker separately [16] or to include the battery of
original markers simultaneously as predictors in multi-
variate regression models [5, 17, 18]. The flowchart
shown in Fig. 2 illustrates the traditional multivariate re-
gression approach for immune markers, neglecting any a
priori knowledge about the existing underlying biological
mechanisms or pathways. From a statistician’s perspec-
tive, this approach is vulnerable to serious methodo-
logical flaws that potentially can invalidate the results.
The most frequent are: i) type I error inflation from
multiple testings, ii) estimation problems due to multi-
collinearity or neglect of measurement error, and most
importantly, iii) type II errors, i.e. missing true associa-
tions, because statistical analysis is based on immune
markers that only reflect a small part of the variation of
the underlying causal immunological mechanism.
Fig. 1 Conceptual model: The figure visualizes current
immunological concepts underlying atopic diseases and allergy.
First, immuno-stimulating factors, e.g. infections or exposure to
dust mite excretion or to helminths exert differential effects on
Th1-, Th2 or TReg responses. In concert these mechanisms are
presumed to affect the Th1/Th2 balance considered to be a major
determinant for regulation of specific IgE that is a predictor for a positive
skin pricktest (SPT). Further downstream, the model assumes that T-Reg
modifies the effect of Th1/Th2 balance on the regulation of specific IgE
antibodies as well as the effect of specific IgE on positivity of skin
pricktest (SPT)
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Fig. 2 Traditional approach vs. framework approach for statistical analysis of multiple immune markers. The left side illustrates the conventional
statistical regression approach selecting potentially relevant markers primarily on the basis of statistical significance in a multivariate regression
model. The right side illustrates the proposed approach incorporating a priori existing immunological knowledge (1) in combination with
appropriate statistical methods (2-6). The aim is to iteratively aggregate information from single measurements (2) to summary indices reflecting
the underlying immunological construct (3-4) either to further aggregate these summary indices to joint distribution constructs such as Th1/Th1
balance (5) and/or to explore the inter-relationship of these summary indices/joint distribution indicators in multiple regression analysis (6). See
text for further details
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In this paper, we present an extension of a previously
described work [19], an analytical framework approach
aimed at analysing multiple immune markers clustered
at two functional levels by integrating existing know-
ledge about the underlying immunological mechanisms
(Fig. 2). We illustrate the application of our approach to
cytokine data from a large immuno-epidemiological
study (SCAALA Salvador), which is aimed at investigat-
ing risk factors and immunological pathways for atopic
diseases and asthma.
Methods
This section consists of two parts. First, we describe the
dataset used to illustrate the application of our analytical
approach. Secondly, we present the theoretical frame-
work for the analytical strategy.
Study population
The SCAALA Salvador study enrolled 1445 children
from Salvador in northeastern Brazil, a large urban cen-
ter with a population of 2.8 million and a high preva-
lence of asthma symptoms such as wheezing (31 %) and
atopy (38 %). The design of the study has been described
in detail elsewhere [20]. Of the 1445 children originally
included in the study, we obtained cytokine measure-
ments for a subpopulation of 1006 children. Of those,
we excluded 59 children with negligible mitogen response
for all cytokines measured, likely due to laboratory errors.
Of the remaining 957 children, we analysed data from 818
children with valid values for all 20 measurements (i.e.
four cytokines and five immunological conditions).
Immunological measurements
Venous blood was collected into heparinized tubes
and cultured at a dilution of 1:4 in RPMI (Gibco,
Auckland, New Zealand) supplemented with 10 mM
glutamine (Sigma-Aldrich, St. Louis, MO, USA) and
100 μg/mL gentamicin (Sigma-Aldrich, St. Louis, MO,
USA). We measured the production of four cytokines,
IFN-γ, IL-5, IL-13, and IL-10, in supernatant fluids
collected from whole blood cultures using commer-
cially available antibody pairs and recombinant cyto-
kine standards (BD Pharmingen, San Diego, CA,
USA) by sandwich ELISA, according to the manufac-
turer’s instructions. Cytokine concentrations were de-
termined by interpolation of standard curves. The
detection limits (low/high) for each cytokine were
15.6/500 pg/mL, 62.5/4000 pg/mL, 18.5/300 pg/mL,
and 31.3/500 pg/mL for IL-5, IL-13, IFN-γ, and IL-10,
respectively. For each cytokine we obtained five differ-
ent measurements for the different culture conditions.
Whole blood cultures were started within 6 h of
blood collection and were maintained in a humidified
environment of 5 % CO2 at 37 °C for 24 h for
detection of IL-10 and for 5 days for the detection of
IL-13, IL-5, and IFN-γ in the presence of pokeweed
mitogen (MITO, 2.5 μg/mL) (PWM; Sigma-Aldrich,
St. Louis, MO, USA) media alone (spontaneous pro-
duction/negative control (NC)), and the antigens As-
caris lumbricoides (ASC, 10 μg/mL), Blomia tropicalis
(BLOM, 40 μg/mL), and Dermaphagoides pteronyssi-
nus (DERM, 5 μg/mL), details of the cell culture
stimulation experiments are described elsewhere (for
ASC [21], for BLOM/DERM [20]). Cytokine measure-
ments below detection limits were considered “non-
responders” and assigned a cytokine concentration
equal to the lower detection limit, while measure-
ments above the detection limit were assigned a con-
centration equal to the upper detection limit. Children
with detectable levels of cytokines (i.e. responders) were
assigned to ordered categories with cut-offs based on me-
dian or tertiles for each cytokine and culture condition. IL-
5 and IL-13 responses to mitogen, for which there was a
higher proportion of responders, were classified into four
categories (non-, low, intermediate, and high responders).
All other measures were classified into three categories
(non-, low, and high responders). We measured four differ-
ent specific IgEs (sIGE) specific to Dermaphagoides ptero-
nyssinus, Blomia tropicalis, Periplaneta americana, and
Blatella germanica) in serum according to the manufac-
turer’s instructions (Phadia Diagnostics AB, Uppsala
Sweden).
Software
All statistical analyses were conducted using the stat-
istical software package STATA (StataCorp. 2011.
Stata Statistical Software: Release 13. College Station,
TX: StataCorp LP).
Analytical framework for statistical analysis of
multiple immune biomarkers
Figure 2 contrasts the traditional regression approach
and the suggested framework approach. Both analytical
approaches start with an outcome variable of interest,
e.g. a surrogate endpoint or intermediate biomarker such
as specific IgE and potential immunological predictor
variables, such as cytokines. In the Additional file 1 we
contrast results of applying both the traditional ap-
proach and the framework approach to a typical im-
munological outcome (sIgE); these are further compared
in the discussion section. In the following section we de-
scribe the suggested framework step by step.
Step 1: Grouping immune markers by using pre-existing
knowledge
The objective of the first step is to maximize the use of
existing immunological knowledge (Figs. 1 and 2, step 1).
To achieve this in immuno-epidemiological studies,
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researchers should group the immune markers according
to a conceptual model that graphically represents the
proposed relationships of each immune marker to an
underlying immunological mechanism and the inter-
relationship between these. Often a multilevel causal
framework is necessary with multiple markers for each
level. In allergy research, immunologists typically classify
cytokines according to distinct types of immune responses
(Th1 response, Th2 response, or regulatory (T-Reg) re-
sponse). Further they obtain for each cytokine multiple
measurements under different immunological condi-
tions (e.g. from antigen-, mitogen- or non-stimulated
cell culture experiments). In the multilevel context we
consider level 1 as the multiple markers for a particular
cytokine and level 2 as the different cytokine relating to
a larger mechanism (e.g. IL-5 and IL-13 are both Th2
cytokines). As an example, the two-level conceptual
framework for the cytokine data from the SCAALA
study is shown in Fig. 3. We will discuss this framework
in detail later in the results section.
Step 2: Data exploration, data recoding
The objective of the second step is to examine the statis-
tical properties of each measurement (Fig. 2, step 2a)
and to employ both meaningful and statistically appro-
priate transformations and recoding (Fig. 2, step 2b). If
this cannot be achieved, researchers may decide to omit
the entire measurement; in SCAALA, for example, the
TGF-ß measures could not be used due to assay mal-
function. Empirically, the best approach is to assume
that none of the data will follow a perfect normal distri-
bution but will instead suffer from various violations of
distributional assumptions, such as extreme skewness,
non-detections, missing data, ceiling effects, or bimodal
distributions. For specific distributional forms, data
transformations can be used to achieve approximate
normal distributions [6]. If data are truncated, for ex-
ample by the “detection limits” of the assay, approaches
such as the Kaplan-Meier method (for censored data) or
the generalized Wilcoxon test may be applied to use this
data for epidemiological association testing [10]. If the-
oretically justified, a simpler and more straightforward
approach is to recode the data into distinct response cat-
egories (e.g. no, low, or high response). Cut points for
defining response categories must be carefully chosen.
However, unfortunately, in contrast to other areas of
medical research such agreed cut-off values for immuno-
logical experiments often do not exist. In this case, cut
points for categorisation should be based on characteris-
tics of the distribution of the measurements, such as
quantiles (e.g. median, tertiles, or quartiles). We strongly
suggest refraining from bias that introduces oversimplifi-
cation, e.g. categorising normally distributed continuous
data into dichotomous categories such as low and high
responders.
Step 3: Intramarker (intragroup) analysis
Having arrived at statistically usable operationalisations
of individual measurements in step 2, the objective of
this step is to study the associative patterns within a
level 1 immunological variable (Fig. 2, step 3a) and to
search for further meaningful and statistically justified
aggregation to summary scores (Fig. 2, step 3b). For
example, association analysis of different stimulation
methods for the same cytokine in culture experiments
may suggest deriving one or more stimulation aggregate
scores. Table 1 provides an overview of statistical
methods for interdependence analysis and data aggrega-
tion of immunological markers, depending on the prop-
erties of the measurement identified in step 2. A good
overview of the specific choice of methods is presented
in our previously published guide for immunologists
[19], while other authors provide details about factor
analytic methods for continuous variables [22] or corres-
pondence techniques for binomial, nominal, or ordinal
variables [23]. As this step is crucially important, re-
searchers should always first visually explore bivariate
associations using contingency tables, correspondence
bi-plots, or scatter plots (see examples from the present
study in the Additional file 1).
The most important part of step 3 is deciding upon
the potential aggregation of measurements to level 1
scores, e.g. whether measurements from various stimula-
tion experiments with one cytokine read-out may be ag-
gregated to an overall cytokine response score or not.
We suggest the following criteria (see legend of Table 1
for decision cut-offs):
1) Strong but simple positive association patterns
(i.e. high correlation or strong correspondence for
categorical data) between a set of immune markers
indicate the presence of a major underlying
immunological mechanism. In this case,
measurements should be combined using simple
aggregation functions, such as the average response
(for continuous data) or the maximum response (for
categorical or ordinal data).
2) If multivariate correlation or correspondence
analysis identifies weak to moderate associations or a
more complex association pattern (e.g. markers with
heterogeneous strengths of association to one or
more underlying components), investigators should
seek to reduce the multidimensional data to an
immunologically meaningful factor solution. The
resulting summary scores are weighted averages of
the original markers, with factor loadings
representing the weights.
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Fig. 3 (See legend on next page.)
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3) If no meaningful pattern is observed, investigators
should interpret the measures as
“immunologically independent”, with each measure
likely to represent different underlying immunological
phenomena. As a general rule, the aggregation of such
independent markers to simple summary scores (e.g.
the sum of response) should be avoided because
information is lost; the interpretation of aggregated
independent markers is more complex.
Step 4: Intermarker analysis
If the data are conceptually structured in multiple levels,
e.g. an immunological mechanism (level 2) being operatio-
nalised by responses of different cytokines, which in turn
were obtained from measurements during multiple stimu-
lation assays (level 1), the analytical strategy of step 3
should be repeated on the obtained aggregate scores from
step 3. The objective again is to explore association pat-
terns (Fig. 2, step 4a) allowing to further aggregate the
data to immunological functional indices (or aggregated
immunological scores) (Fig. 2, step 4b). For example, im-
munologists know that both IL-5 and IL-13 are produced
by Th2 cells and thus show a strong association pattern
due to this common mechanism (Th2-related immune
response). In this case aggregating the antigen-specific
summary scores for IL-5 and IL-13 (derived from step 3)
to a Th2 summary score may be justified.
Step 5: Interdependence or dependence analysis among
the immunological summary indices
This step aims to explore the inter-relationship among
the aggregated summary scores (Fig. 2, step 5a), either
to elucidate possible interdependence or to perform de-
pendence analysis. If there is no clear a priori hypothesis
with respect to the direction of the relationship, the ana-
lytical approaches from steps 3 and 4 are repeated. In
contrast, if investigators a priori assume an underlying
mechanism, the assumptions about the direction of this
mechanism should be incorporated in the model. For ex-
ample, if researchers assume that T-Reg responses affect
the Th2 response (and not vice versa), a regression
model using the Th2 score as the dependent variable
and T-Reg score as the independent (predictor) variable
may be warranted (Fig. 2, step 5b). Further details de-
scribing the differences between dependence and inter-
dependence analysis are described elsewhere [19].
Step 6: Dependence analysis based on the immunological
summary scores
The final step aims to relate the immunological summary
scores derived in steps 1 to 5 to outcomes typically observed
in immunological studies (e.g. clinical outcomes like skin
prick test, asthma symptoms, or intermediate immune
markers such as plasma sIgE concentrations) (Fig. 2, step 6).
Results
To illustrate the application of the analytical framework
we used data from 818 children with valid measure-
ments of 20 immune markers, namely concentrations of
four different cytokines (IL-10, IL-5, IL-13, and IFN-γ)
obtained under five different stimulation experiments.
Step 1: Grouping of variables using pre-existing knowledge
Figure 3 is a graphical representation of the pre-conceived
relationships at the design of the study. The bullets refer to
the steps of the analytical approach; step 1 is not shown.
Conceptually, we consider the measurements to be hier-
archically clustered in a two-level structure. At level 1 we
consider for each cytokine the measurements obtained
from the five stimulation experiments, and at level 2 we
consider three inter-related latent immunological con-
structs: 1) an immune regulatory network, which is viewed
as being interrelated with 2) Th1 responses and 3) Th2 im-
mune responses. The regulatory response is quantified by
concentrations of IL-10 and TGF-ß, the Th1 response by
concentrations of IFN-γ and IL-2, and the Th2 response by
concentrations of IL-5 and IL-13. In the present study, data
from TGF-ß measurements were unusable due to assay
malfunction and IL-2 measurements were not available due
to funding constraints. We categorised the level 1 measure-
ments into four groups. The first group includes the mite-
specific responses B. tropicalis (BLOM) and D. pteronyssi-
nus (DERM), which we assume a priori as highly immuno-
logically related. In the second group, we place the
responses to A. lumbricoides (ASC), which we expect to
reflect a distinct and more complex helminth-induced
immune response. In the third group, we consider the
mitogen responses (MITO) presumed to reflect the
(See figure on previous page.)
Fig. 3 Conceptual model incorporating three inter-related immunological mechanisms (Th1-response, Th2-response, T-regulatory response) quantified by a
battery of hierarchically clustered immune markers (multiple measurements of different cytokines). For each cytokine concentrations were determined from
different cell cultures (ASC: A. lumbricoides specific response, BLOM: B. tropicalis specific response, DERM: D. pteronyssinus specific response, MITO: pokeweed
mitogen response, NC: unstimulated spontaneous response). The model incorporates a-priori knowledge about which cytokine relates to which specific
mechanism, e.g. to use IFN-y as a marker for the Th1 response or to use IL-5 as a marker for the Th2 response. Further knowledge excludes the ASC measure
assumed to reflect a more complex difficult to interpret immune response. The numbered bullets (2-5) correspond to the analytical steps illustrated in
Fig. 2 (step 1 not shown) the legend to the bullet briefly summarizes the analytical step
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maximum possible response, and in the fourth group the
spontaneous non-stimulated cytokine responses. Further
details on our a priori hypotheses about the presumed im-
munological mechanisms underlying the different cytokine
measurements are presented in the legend to Fig. 3.
Step 2: Data exploration, data recoding
Box plots visualising the distribution of the original data
are shown in the (Additional file 1: Figure S1). We ob-
served non-detects for all 20 cytokine measurements in
considerable proportions of the participants (range 2.6 %
to 97.9 %). Moreover, exploratory data analysis consider-
ing the cytokine concentration of responding individuals,
including histograms and distributional plots (data not
shown), suggested severe deviations from normality.
Both observations indicated the necessity for a unifying
ordinal categorisation of the data with the objective of
retaining maximum possible information. We thus
decided to pursue a three-category approach, except for
mitogen responses of IL-5 and IL-13, where four
categories were warranted. In the absence of an agreed
immunological cut-off, we classified non-detects as non-
responders, below-median measurements of detectable
quantities as low responders, and above-median mea-
surements as high responders. For mitogen responses of
IL-5 and IL-13, detectable measurements were grouped
using tertiles as cut-offs (low, intermediate, and high
responders). Additional file 1: Table S1 provides the dis-
tributions of the recoded categorical data. As expected,
cytokine response rates were higher in mitogen-
stimulated cultures (78 % to 97 % responders) compared
to antigen-specific cultures (3 % to 23 %) and unstimu-
lated cultures (6 % to 35 % responders).
Step 3: Intramarker (intragroup) analysis
This step aimed to detect new or confirm a priori hy-
pothesized associations at level 1 (associations within
the multiple measurements of the same cytokine).
Table 2 shows a summary of this analytical step, displaying
for each cytokine and all pairs of bivariate comparisons
the association measure (Goodman and Kruskal’s-γ) and
the p-value. To further illustrate the analyses conducted in
this analytical step, we show detailed results for one cyto-
kine (IL-13) in the (Additional file 1: Table S2 and Figure
S2). The interdependence pattern identified among the
five multiple measurements show that these measures
quantify distinct immunological phenomena: the specific
responses to different antigens, the non-specific response
(MITO), and the unstimulated spontaneous immune re-
sponse (NC). In more detail, we observed a very strong
positive association between the mite-specific responses
(BLOM, DERM) for IFN-γ, IL-5, and IL-13 (with γ ran-
ging from 0.73 to 0.85); for IL-10 the correlation was sub-
stantially lower (γ = 0.35). In contrast, the mite-specific
responses (BLOM, DERM) showed substantially weaker
associations with helminth-specific responses (ASC), with
the exception of IL-13, where all three antigen measures
were highly related. This finding corroborates our a priori
hypothesis to consider ASC as a separate immunological
measure in any further analyses. However, we decided to
aggregate the DERM and BLOM measures for each cyto-
kine to a summary scale quantifying the overall mite-
induced response (further called the ANTI scale) by con-
sidering the highest achieved response for either antigen.
The distribution of this measure is shown in Table 3. Fur-
ther, we found that for all cytokines the spontaneous (NC)
and mitogen responses (MITO) showed absence of associ-
ation (or inconsistent heterogeneous association patterns)
with the antigen-specific measures and should thus be
considered as separate scales in any further analyses.
Step 4: Intermarker analysis
In this step, we conducted an intercytokine analysis
examining the association patterns between any pair of
cytokines on three different scales (ANTI, MITO, and
NC) (Table 4). As expected, we observed for the two
Table 1 Statistical approaches for interdependence analysis of immunological markers dependent on the scale of measurement
Scale of measurement Bivariate methods Multivariate methods
Binomial (e.g. positive, negative) Contingency table; tests: Chi-square or Fisher’s exact test;
association measure: phi coefficient, Yule’s Q
Multilayer contingency table, classification trees
Nominal (e.g. Th1, Th2, or T-Reg) Contingency table; tests: chi-square or Fisher’s exact test;
association measure: contingency coefficient
Multilayer contingency tables, correspondence
analysis, classification trees
Ordinal (e.g. low, medium, high) Contingency table; tests: chi-square or Fisher’s exact test,
tau test; association measure: Spearman-Rank correlation,
Kendall’s Tau or Goodman and Kruskal’s γ
Multilayer contingency tables, correspondence
analysis, classification trees
Continuous (non-normal
distributed)
Scatter Plots; test: Spearman-Rank Correlation, criteria:
Kendall’s Tau or Goodman and Kruskal’s γ
Factor analytic techniques: e.g. principal
component analysis
Continuous (normal distributed) Scatter Plots; test and association measure: Pearson
correlation coefficient
Factor analytic techniques: e.g. principal
component analysis
Rules of thumb for quantifying the strength of association based on the magnitude of association measures (e.g. Goodman and Kruskal’s γ): no association: 0 < |γ| < = 0.25,
weak: 0.25 < |γ| < 0.50, moderate: 0.50 < |γ| < = 0.75, strong: |γ| > 0.75
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Th2-related cytokines IL-5 and IL-13 positive associations
on both antigen and mitogen scales (γ = 0.58, P = 0.001 for
ANTI, and γ = 0.62, P < 0.001 for MITO), but no associ-
ation on the spontaneous scale (γ = -0.22, p = 0.451 for
NC). These results were corroborated by correspondence
analysis (Additional file 1: Figure S3). Given this moderate
positive association, we calculated a Th2 summary score
by considering the highest observed response category of
either Th2-related cytokine (maximum response of IL-5
and IL-13). We calculated the Th2 score for both the anti-
gen and mitogen scale.
Considering the antigen scale, the Th1 response (IFN-γ)
showed independence of the Th2 response (IL-5, IL-13) but
positive association with the regulatory response (IL-10).
Further, we found that all four cytokines showed positive
association patterns on the mitogen scale but no associ-
ation on the spontaneous response. As explained above, the
present study yielded only one cytokine each for the
Table 2 Summary of bivariate association analyses between each culture condition for each cytokine using data collected from 818
children in SCAALA Salvador
Cytokine Measure ASC BLOM DERM MITO
IFN-γ BLOM γ = 0.21, - - -
P = 0.144
DERM γ = 0.77***, γ = 0.73**, - -
P = <0.001 P = <0.001
MITO γ = -0.24, γ = 0.26*, γ = 0.09, -
P = 0.667 P = 0.016 P = 0.653
NC γ = 0.29*, γ = 0.05, γ = 0.11, γ = -0.84***,
P = 0.242 P = 0.593 P = 0.412 P = <0.001
IL-5 BLOM γ = -0.05, - - -
P = 0.585
DERM γ = 0.35*, γ = 0.94***, - -
P = 0.057 P = <0.001
MITO γ = 0.26*, γ = -0.21, γ = 0.19, -
P = 0.047 P = 0.234 P = 0.568
NC γ = 0.38*, γ = 0.61**, γ = 0.76***, γ = 0.09,
P = <0.001 P = <0.001 P = <0.001 P = 0.405
IL-13 BLOM γ = 0.83***, - - -
P = <0.001
DERM γ = 0.83***, γ = 0.85***, - -
P = <0.001 P = <0.001
MITO γ = 0.47*, γ = 0.28*, γ = 0.52**, -
P = <0.001 P = 0.016 P = <0.001
NC γ = 0.43*, γ = 0.70**, γ = 0.45*, γ = 0.09,
P = <0.001 P = <0.001 P = <0.001 P = 0.005
IL-10 BLOM γ = 0.28*, - - -
P = 0.510
DERM γ = 0.69**, γ = 0.35*, - -
P = <0.001 P = <0.001
MITO γ = 0.26*, γ = 0.93***, γ = 0.43*, -
P = 0.326 P = <0.001 P = <0.001
NC γ = -0.03, γ = -0.95***, γ = -0.35*, γ = -0.96***,
P = 0.468 P = <0.001 P = 0.008 P = <0.001
ASC: response in cell culture stimulated by A. lumbricoides, BLOM: response in cell culture stimulated by B. tropicalis, DERM: response in cell culture stimulated by
D. pteronyssinus, MITO: response in cell culture stimulated by pokeweed mitogen, NC: response in nonstimulated cell culture; γ: Goodman and Kruskal’s γ, P: P-value
of chi-square test of independence; Strength of association: * … weak (0.25 < |γ| < =0.5)
** … moderate (0.50 < |γ| < =0.75); *** … strong (0.75 < |γ| < =1); Significant estimates (P<0.05) are shown in bold
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regulatory response and the Th1 response, allowing the
intermarker aggregation step for Th1 and T-Reg constructs
to be skipped.
For any further analysis steps, we considered two
scales (antigen and mitogen) for Th1 and Th2 responses
and three scales (antigen, mitogen, and spontaneous) for
T-Reg responses. In addition, since one of the main hy-
potheses about the immunological mechanisms under-
lying atopic diseases and asthma relates to the balance
of Th1 and Th2 cytokines, we cross-tabulated the Th1
and Th2 aggregated scores considering the joint Th1-
Th2 response. We grouped the data into a Th1/Th2 bal-
ance score with higher values referring to Th2 skewness:
0:Th1 negative and Th2 negative, 1:Th1 positive and
Th2 negative, 2: Th1 positive and Th2 positive, and 3:
Th1 negative and Th2 positive. The balance indicator
was calculated for both antigen and mitogen scale.
Table 5 shows the distributions of the final immuno-
logical summary scores that will be considered in the
next analysis steps.
Step 5: Interdependence or dependence analysis among
the immunological summary scores
In this step, we conducted an exploratory interdepend-
ence analysis among the summary scores Th1, Th2, Th1/
Th2 balance, and T-Reg. A summary of the results is
presented in Table 6; plots of correspondence analysis
are displayed in the (Additional file 1: Figure S5). Three
important findings have emerged: i) Th1/Th2 balance on
the antigen scale presented as independent of T-Reg,
both for spontaneous and mitogen scales (NC:γ = 0.20, P =
0.387, MITO : γ = 0.22, P = 0.313), ii) a weak association
between Th2 response and T-Reg (NC, γ = 0.30, P = 0.008);
iii) for antigen responses no association between Th1 and
Th2 (ANTI, γ = 0.06, P = 0.248), no association between
Th2 and T-Reg (ANTI, γ = -0.02), and small association
between Th1-Th2 balance and T-reg (ANTI, γ = 0.14, P =
0.030); iv) considering the mitogen responses all four sum-
mary scores showed positive associations. The important
consequence of these results for step 6 dependency analysis
is to consider T-Reg and Th1/Th2 balance as independent
immunological variables. We consider the antigen scale as
the primary measure to quantify Th1/Th2 balance and the
spontaneous scale of T-Reg to quantify the immune
regulatory mechanism.
Step 6: Dependence analysis based on the immunological
summary scores
Finally, we illustrate how the immunological summary
scores derived in steps 1 to 5 can be used to describe
the association with an important immunological out-
come (sIgE). We compare the results of our framework
approach with a classical stepwise regression approach
using the log-transformed raw cytokine (Fig. 2). Detailed
results of both approaches are shown in the (Additional
file 1: Table S3). In summary, the traditional stepwise re-
gression approach revealed five significant parameters.
We found a significant strong positive effect of IL-5 (B.
tropicalis), a 10-fold smaller positive effect for IL-5 (D.
pteronyssinus), a 60-fold smaller positive effect of IL-5
(MITO) and IL-10 concentrations (D. pteronyssinus),
and a 20-fold smaller negative association with IFN-γ (B.
Table 3 Distribution of aggregated summary scales for the overall
dust-mite antigen-specific response using data collected from 818
children in SCAALA Salvador
Cytokine IFN-γ IL-5 IL-13 IL-10
n % n % n % n %
no response 604 73.8 796 97.3 652 79.7 22 2.7
low response 94 11.5 11 1.3 77 9.4 152 18.6
high response 120 14.7 11 1.3 89 10.9 644 78.7
Total 818 100.0 818 99.9 818 100.0 818 100.0
Maximum immune responses observed in cell cultures stimulated by B. tropicalis
or D. pteronyssinus
Table 4 Summary of result of intercytokine analysis using data collected from 818 children in SCAALA Salvador
Measure Cytokine IL-5 IL-13 IL-10
ANTI IFN-γ γ = -0.36*, P = 0.669 γ = 0.12, P = 0.324 γ = 0.33*, P = 0.011
IL-5 γ = 0.58**, P = 0.001 γ = 0.06, P = 0.242
IL-13 γ = -0.04, P = 0.648
MITO IFN-γ γ = 0.53**, P < 0.001 γ = 0.65**, P < 0.001 γ = 0.46*, P < 0.001
IL-5 γ = 0.62**, P < 0.001 γ = 0.27*, P < 0.001
IL-13 γ = 0.19, P = 0.008
NC IFN-γ γ = 0.18, P = 445 γ = 0.09, P = 0.095 γ = 0.04, P = 0.500
IL-5 γ = -0.22, P = 0.451 γ = -0.39*, P = 0.620
IL-13 γ = 0.07, P = 0.484
ANTI: Maximum immune response observed in cell cultures stimulated by B. tropicalis or D. pteronyssinus, MITO: response in cell cultures stimulated by pokeweed
mitogen, NC: response in non-stimulated cell cultures; γ: Goodman and Kruskal’s γ, P: P-value of chi-square test of independence, significant associations are shown
in bold; Strength of association: * … weak (0.25 < |γ| < =0.5), ** … moderate (0.50 < |γ| < =0.75)
*** … strong (0.75 < |γ| < =1); Significant estimates (P<0.05) are shown in bold
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tropicalis). All other parameters failed to retain
significance.
By contrast, the framework approach results in the
aggregated immunological summary scores that were
included in a multivariate regression model as predic-
tors for sIgE, namely the dummy-coded Th1/Th2
balance score (antigen scale) and the dummy-coded T-
Reg score (spontaneous scale). Since we do not as-
sume any effect of Th1 on sIgE, we recoded the Th1/
Th2 balance score by pooling the first two categories
(Th1-/Th2- and Th1+/Th2-). Moreover, since we ex-
pect a downregulating effect of strong IL-10 responses
we dichotomize the T-Reg score (high vs. low or no re-
sponse). The detailed results are shown in the (Additional
file 1: Table S2, B). Briefly, compared to the reference cat-
egory (absence of Th2 response) the model showed a
strong significant increase of sIgE in the case of a skewed
Th2+ response (Th1-/Th2+: ß = 0.53, P = 0.009) and a
non-significant, substantially smaller increase induced by
a balanced Th2 response (Th1+/Th2+: ß = 0.30, P =
0.304). Additionally, the model reveals a negative but
non-significant effect of a high spontaneous IL-10 re-
sponse (ß = -0.38, P = 0.298). We also investigated the
inclusion of interaction terms between Th1/Th2 bal-
ance and T-Reg that did not show any significant ef-
fects. We will not discuss this dependence analysis
any further here; the detailed effects of cytokine pat-
tern on sIgE and other endpoints observed in
SCAALA, such as the skin prick test or clinical out-
comes like allergy or asthma symptoms, will be exam-
ined in future work.
Traditional regression approach
In contrast, the application of the traditional stepwise
regression to the original cytokine measures as described
in Fig. 2 (left side) yielded results that were not straight-
forward to interpret. While finding a strong positive ef-
fect of IL-5 and a negative effect of IFN-γ (both specific
to B. tropicalis) was consistent with the hygiene hypoth-
esis, the interpretation of other parameters in the final
model was difficult. For example, the much lower effect
of IL-5 (D. pteronyssinus) compared to IL-5 (B. tropica-
lis) or the statistically significant association with high
IL-10 (DERM) might have arisen from multicollinearity
or other peculiarities, such as deviation from the
Table 5 Distributions of final immunological summary scales
derived from cytokine data collected from 818 children in
SCAALA Salvador
T-Reg response ANTI MITO NC
n % n % n %
no response 22 2.7 21 2.6 749 91.6
low response 152 18.6 121 14.8 36 4.4
high response 644 78.7 676 82.6 33 4.0
Th1 response ANTI MITO
n % n %
no response 604 73.8 71 8.7
low response 94 11.5 137 16.7
high response 120 14.7 610 74.6
Th2 response ANTI MITO
n % n %
no response 642 78.5 99 12.1
low response 79 9.7 162 19.8
intermediate response - - 218 26.7
high response 97 11.8 339 41.4
TH1/TH2 balance ANTI MITO
n % n %
no TH1 resp./no TH2 resp. 481 58.8 36 4.4
TH1 resp./no. TH2 resp. 161 19.7 63 7.7
TH1 resp./TH2 resp. 53 6.5 684 83.6
no TH1 resp./TH2 resp. 123 15.0 35 4.3
ANTI: Maximum immune response observed in cell cultures stimulated by B.
tropicalis or D. pteronyssinus, MITO: response in cell cultures stimulated by
pokeweed mitogen, NC: response in non-stimulated cell cultures
Table 6 Results of interdependence analysis among the immunological summary scores
Immune response Th2 response T-Reg response
Measure ANTI MITO ANTI MITO NC
Th1 response ANTI γ = 0.06, P = 0.248 γ = 0.25*, P < 0.001 γ = 0.33*, P = 0.011 γ = 0.14, P = 0.504 γ = 0.11, P = 0.302
MITO γ = -0.01, P = 0.723 γ = 0.59**, P < 0.001 γ = 0.42*, P < 0.001 γ = 0.46*, P < 0.001 γ = 0.26*, P = 0.021
Th2 response ANTI - - γ = -0.02, P = 0.509 γ = -0.13, P = 0.458 γ = 0.30*, P = 0.008
MITO - - γ = 0.36*, P < 0.001 γ = 0.26*, P < 0.001 γ = 0.10, P = 0.280
Th1/Th2 balance ANTI - - γ = 0.14, P = 0.030 γ = -0.01, P = 0.437 γ = 0.20, P = 0.387
MITO - - γ = 0.39*, P < 0.001 γ = 0.17, P < 0.001 γ = 0.22, P = 0.313
ANTI: Maximum immune response observed in cell cultures stimulated by B. tropicalis or D. pteronyssinus, MITO: response in cell cultures stimulated by pokeweed
mitogen, γ: Goodman and Kruskal’s γ, P: P-value of chi-square test of independence, significant associations shown in bold; strength of association: * …
weak (0.25 < |γ| < =0.5)
** … moderate (0.50 < |γ| < =0.75), *** … strong (0.75 < |γ| < =1); Significant estimates (P<0.05) are shown in bold
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multivariate normal distribution of this data (more de-
tails, Additional file 1).
Discussion
In the present work, we present an approach for the
statistical analysis of multiple, often related immuno-
logical markers that capitalizes on a priori existing
knowledge and insight into immunological mechanisms.
We illustrated the proposed approach using a dataset
from a large immuno-epidemiological study (SCAALA
Salvador) conducted to investigate the potential im-
munological mechanisms underlying atopic diseases and
asthma. The immune markers collected in this study in-
cluded multiple measurements of different cytokines ob-
tained under different whole blood culture conditions.
The application of our approach to the cytokine data
collected in SCAALA Salvador suggested Th1/Th2
skewness as the most relevant predictor for elevated sIgE
levels, rather than the Th2 response itself. Further, the
approach suggested a potential independent down-
regulating effect of strong T-regulatory spontaneous re-
sponses. In contrast, the traditional stepwise regression
approach using the full dataset and all original cytokine
measures yielded results that were difficult to interpret
(e.g. a statistically significant association of sIgE and the
IL-10 release in response to the DERM mite antigen).
What is the research implication of this approach and
why it might prove superior to the traditional statistical
approach? The suggested approach is still based on com-
mon statistical concepts such as the idea of latent vari-
ables. However, the stepwise implementation is less data
driven because each analytical step is guided by a con-
ceptual model that specifies the presumed underlying
immunological mechanism. Conceptually, the approach
resembles the work employed by empirical scientists
from other areas, e.g. the social sciences, aimed to inves-
tigate complex phenomena involving concepts that are
not directly observable (e.g. intelligence or socioeco-
nomic status). Approaches like structural equation mod-
elling are frequently used to implement the underlying
concepts by using measurement models based on multi-
layered indicator variables.
In the proposed approach, we invite immuno-
epidemiologists to follow this well-developed approach of
investigation including the idea of latent variables. Our
step 1 postulates to order or cluster measurements ac-
cording to a preconceived conceptual model. This should
reflect the best available knowledge at the time of con-
ducting the analysis. For example, in the present study, re-
searchers sought to characterize the T-regulatory response
by obtaining concentrations of IL-10 and TGF-ß in stimu-
lated and non-stimulated cell cultures. Our step 2 deals
with the problem that rarely immunological data follow a
normal distribution. Researchers need to make decisions
how to control the statistical peculiarities and to reduce
the data, if necessary, e.g. to binary or ordered variables
that are amenable to downstream statistical procedures.
In the present example, the non-normal distribution of
the data (see Additional file 1) required to employ differ-
ent categorization levels. Step 3 is an analogy to forming
scales from individual questionnaire items. In theory, such
aggregated scores may yield less measurement error and
provide information more related to the underlying con-
struct. In the present study, the IL-5, IL-13, IFN- γ and
IL-10 aggregated antigen scores reflect this step. Step 4 al-
lows further aggregation, just like different scales may ag-
gregate to a well-being index in psychosocial research. In
the present example, the IL-5 and IL-13 scores are further
aggregated to an overall aggregated Th2 score. Like in the
mentioned psychosocial example both step 3 and step 4
require active and thoughtful participation of the re-
searcher to consider the possible content validity of score
or index formation in the context of concurrent immuno-
logical knowledge. Once the researcher has arrived at ag-
gregated non redundant measures that reflect the
underlying construct simple statistical procedures can be
employed to quantify the relationship between the con-
structs (e.g ratios or cross tables examining the joint dis-
tribution). In the present example this step 5 involved
constructing a Th1/Th2 balance score just by considering
the joint distribution of Th1 and Th2 responses. In the
final step, we proposed simple regression models aimed to
relate the immunological summary constructs to out-
comes of interest are the objective of the final step 6 (e.g.
regressing sIgE levels onto Th1/Th2 balance and T-
regulation). Results from these models are easier to inter-
pret than models using the original markers because they
better quantify the impact of the potentially causing
mechanisms on the outcomes of interest.
The strengths of this approach simultaneously bears
the possible limitations. The strength at each step is to
include the best available immunological knowledge in
decision making about statistical procedures. For
example, in step 2 decisions must be made to deal with
missing data, with non-normally distributed data,
whether the aggregated score has binominal (response
yes-no) or ordinal characteristics (no-low-medium-high
response). The limitation of the approach is that each
step may introduce potential bias (e. g. from arbitrary
choices of cut-offs). However, if in future reports using
this approach every step is carefully documented, to-
gether with providing the raw data in appendices or
journal repositories, other researchers may choose to re-
peat the analysis using different aggregation modalities
or to introduce new conceptual models as scientific
insight progresses. Such informed, transparent and con-
scious analytical process may contribute to a better un-
derstanding of complex immunological mechanisms.
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Conclusions
We suggest a systematic analytical approach for complex
immuno-epidemiological data that capitalizes on a
framework incorporating pre-existing knowledge about
the underlying immunological phenomena. Our ap-
proach mimics the method of latent variable approaches
such as principal components analysis, latent class ana-
lysis or structural equation modelling. However, with
less harsh data assumption our analytical strategy cir-
cumvents peculiarities often encountered in real data
such as violation of distributional assumptions or multi-
collinearity. The proposed approach may assist applied re-
searchers in the area of immuno-epidemiology to quantify
the immunological mechanisms underlying immunologic-
ally mediated diseases, such as allergic disease or asthma.
Using immunological summary scores that reflect distinct
immunological concepts instead of the correlated original
markers should substantially simplify data analysis in stud-
ies on relationships among non-immunological factors, im-
mune responses, and disease.
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